These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30777126)

  • 41. Thickening of the cauda equina roots: a common finding in Krabbe disease.
    Hwang M; Zuccoli G; Panigrahy A; Rodriguez D; Poe MD; Escolar ML
    Eur Radiol; 2016 Oct; 26(10):3377-82. PubMed ID: 27137647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new compound heterozygous mutation in adult-onset Krabbe disease.
    Meng X; Li Y; Lian Y; Li Y; Du L; Xie N; Wang C
    Int J Neurosci; 2020 Dec; 130(12):1267-1271. PubMed ID: 32064984
    [No Abstract]   [Full Text] [Related]  

  • 43. Later onset phenotypes of Krabbe disease: results of the world-wide registry.
    Duffner PK; Barczykowski A; Kay DM; Jalal K; Yan L; Abdelhalim A; Gill S; Gill AL; Carter R
    Pediatr Neurol; 2012 May; 46(5):298-306. PubMed ID: 22520351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weighing the evidence for newborn screening for early-infantile Krabbe disease.
    Kemper AR; Knapp AA; Green NS; Comeau AM; Metterville DR; Perrin JM
    Genet Med; 2010 Sep; 12(9):539-43. PubMed ID: 20601893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insights into the Pathogenesis and Treatment of Krabbe Disease.
    Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral neuropathy in Krabbe disease: electrodiagnostic findings.
    Siddiqi ZA; Sanders DB; Massey JM
    Neurology; 2006 Jul; 67(2):263-7. PubMed ID: 16864819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Favorable outcome of hematopoietic stem cell transplantation in late-onset Krabbe disease.
    Mitsutake A; Matsukawa T; Iwata A; Ishiura H; Mitsui J; Mori H; Toya T; Honda A; Kurokawa M; Sakai N; Tsuji S; Toda T
    Brain Dev; 2023 Aug; 45(7):408-412. PubMed ID: 37080866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphocyte Galactocerebrosidase Activity by LC-MS/MS for Post-Newborn Screening Evaluation of Krabbe Disease.
    Liao HC; Spacil Z; Ghomashchi F; Escolar ML; Kurtzberg J; Orsini JJ; Turecek F; Scott CR; Gelb MH
    Clin Chem; 2017 Aug; 63(8):1363-1369. PubMed ID: 28592445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Krabbe disease: neurophysiologic studies and MRI correlations.
    Husain AM; Altuwaijri M; Aldosari M
    Neurology; 2004 Aug; 63(4):617-20. PubMed ID: 15326231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Globoid cell leukodystrophy of adult. A first case in Poland].
    Jastrzębski K; Czartoryska B; Klimek A
    Neurol Neurochir Pol; 2013; 47(3):278-82. PubMed ID: 23821426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.
    Sakai N
    Brain Dev; 2009 Aug; 31(7):485-7. PubMed ID: 19332366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients.
    Berardi AS; Pannuzzo G; Graziano A; Costantino-Ceccarini E; Piomboni P; Luddi A
    Mol Genet Metab; 2014 Aug; 112(4):294-301. PubMed ID: 24913062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a newborn screening tool based on bivariate normal limits: using psychosine and galactocerebrosidase determination on dried blood spots to predict Krabbe disease.
    Langan TJ; Orsini JJ; Jalal K; Barczykowski AL; Escolar ML; Poe MD; Biski CK; Carter RL
    Genet Med; 2019 Jul; 21(7):1644-1651. PubMed ID: 30546085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developmental outcomes of cord blood transplantation for Krabbe disease: A 15-year study.
    Wright MD; Poe MD; DeRenzo A; Haldal S; Escolar ML
    Neurology; 2017 Sep; 89(13):1365-1372. PubMed ID: 28855403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late infantile onset krabbe disease in siblings with cortical degeneration and absence of cerebral globoid cells.
    Del Bigio MR; Chudley AE; Booth FA; Pacin S
    Neuropediatrics; 2004 Oct; 35(5):297-301. PubMed ID: 15534764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developmental and functional outcomes in children with a positive newborn screen for Krabbe disease: a pilot study of a phone-based interview surveillance technique.
    Duffner PK; Granger C; Lyon N; Niewczyk P; Barczykowski A; Bauer S; Msall ME
    J Pediatr; 2012 Aug; 161(2):258-63.e1. PubMed ID: 22381022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why must the debate continue on Krabbe disease newborn screening?
    Pike-Langenfeld S
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):153-155. PubMed ID: 36056676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Late-onset Krabbe disease (globoid cell leukodystrophy): clinical and biochemical features of 15 cases.
    Kolodny EH; Raghavan S; Krivit W
    Dev Neurosci; 1991; 13(4-5):232-9. PubMed ID: 1817026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
    Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
    Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe Disease.
    Thompson-Stone R; Ream MA; Gelb M; Matern D; Orsini JJ; Levy PA; Rubin JP; Wenger DA; Burton BK; Escolar ML; Kurtzberg J
    Mol Genet Metab; 2021; 134(1-2):53-59. PubMed ID: 33832819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.